The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 16, 2010

Filed:

Apr. 12, 2005
Applicants:

Chu-biao Xue, Hockessin, DE (US);

Ganfeng Cao, Bear, DE (US);

Taisheng Huang, Wilmington, DE (US);

Lihua Chen, Boothwyn, PA (US);

KE Zhang, Wilmington, DE (US);

Anlai Wang, Wilmington, DE (US);

David Meloni, Bear, DE (US);

Rajan Anand, Wilmington, DE (US);

Joseph Glenn, Sicklerville, NJ (US);

Brian W. Metcalf, Moraga, CA (US);

Inventors:

Chu-Biao Xue, Hockessin, DE (US);

Ganfeng Cao, Bear, DE (US);

Taisheng Huang, Wilmington, DE (US);

Lihua Chen, Boothwyn, PA (US);

Ke Zhang, Wilmington, DE (US);

Anlai Wang, Wilmington, DE (US);

David Meloni, Bear, DE (US);

Rajan Anand, Wilmington, DE (US);

Joseph Glenn, Sicklerville, NJ (US);

Brian W. Metcalf, Moraga, CA (US);

Assignee:

Incyte Corporation, Wilmington, DE (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/497 (2006.01); C07D 247/02 (2006.01); A61K 31/496 (2006.01); A61P 29/00 (2006.01); C07D 237/28 (2006.01); C07D 487/00 (2006.01); C07D 401/04 (2006.01); C07D 403/04 (2006.01); C07D 405/04 (2006.01); C07D 409/04 (2006.01); C07D 411/04 (2006.01); C07D 413/04 (2006.01); C07D 417/04 (2006.01); C07D 419/04 (2006.01); C07D 241/04 (2006.01); C07D 277/22 (2006.01); C07D 307/78 (2006.01); C07D 303/08 (2006.01); C07C 49/297 (2006.01); C07C 33/46 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to compounds of Formula I: wherein variable substituents are defined herein, that modulate the activity of or bind to chemokine receptors such as CCR5. In some embodiments, the compounds of the invention are selective for CCR5. The compounds can be used, for example, to treat diseases associated with chemokine receptor expression or activity such as inflammatory diseases, immune diseases and viral infections.


Find Patent Forward Citations

Loading…